Chronic non-specific low back pain. Dorsalgia, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Years: Range:18-45, males and females Chronic back pain in the area between the twelfth rib and the rump without reference to the lower limbs, which has lasted for more than three months and has no specific cause and has caused problems in performance and physical disability and has not subsided. People with a desire to enter the study
Exclusion criteria
Exclusion criteria: History of neurological disorder Rheumatic diseases Cancer Spinal cord lesions History of surgery Structural injuries of the spine Pregnancy History of therapeutic exercise in the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-Overall static stability index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Biodex device.;Anterior-posterior static stability index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Biodex device.;Internal and external static stability index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Biodex device.;Overall dynamic stability index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Biodex device.;Anterior-posterior dynamic stability index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Biodex device.;Stability index of internal and external dynamics. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Biodex device.;Pain intensity index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: VAS questionnaire.;Disability severity index. Timepoint: The beginning of the study (before the start of the intervention) and the end of the 6-week treatment period. Method of measurement: Oswestry Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Zahedan University of Medical Sciences